WuXi AppTec Co., Ltd. Class H (HK:2359)
:2359
Comparison Results
WuXi AppTec Co., Ltd. Class H
HK$128.40
HK$359.49B
8.95
150.29%
5 Buy
0 Hold
0 Sell
Strong Buy
Wuxi Biologics (Cayman)
HK$35.28
HK$148.55B
11.12
76.93%
11 Buy
1 Hold
0 Sell
Strong Buy
Hangzhou Tigermed Consulting Co., Ltd. Class H
HK$54.00
HK$49.88B
37.05
56.67%
4 Buy
0 Hold
0 Sell
Strong Buy
Pharmaron Beijing Co., Ltd. Class H
HK$24.14
HK$59.24B
18.63
68.12%
4 Buy
0 Hold
0 Sell
Strong Buy
Hansoh Pharmaceutical Group Company Limited
HK$38.46
HK$234.70B
35.71
70.18%
7 Buy
0 Hold
0 Sell
Strong Buy
WuXi XDC Cayman, Inc.
HK$61.60
HK$79.40B
46.00
83.06%
9 Buy
0 Hold
0 Sell
Strong Buy
Performance Comparison
HK:2359
WuXi AppTec Co., Ltd. Class H
128.40
76.80
148.84%
HK:2269
Wuxi Biologics (Cayman)
35.28
14.08
66.42%
HK:3347
Hangzhou Tigermed Consulting Co., Ltd. Class H
41.36
14.53
54.14%
HK:3759
Pharmaron Beijing Co., Ltd. Class H
20.78
8.09
63.74%
HK:3692
Hansoh Pharmaceutical Group Company Limited
38.46
15.91
70.55%
HK:2268
WuXi XDC Cayman, Inc.
61.60
26.25
74.26%